Daniel Grosslight
Stock Analyst at Citi
(3.64)
# 2,106
Out of 4,547 analysts
348
Total ratings
49.3%
Success rate
4.7%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMRS GMR Solutions | Initiated Coverage: Buy | $17 | $12.99 | +30.87% | 1 | Jun 8, 2026 | |
| ALGN Align Technology | Maintained: Buy | $240 | $177.50 | +35.21% | 2 | May 28, 2026 | |
| PHR Phreesia | Reiterated: Hold | $10 → $12 | $10.60 | +13.21% | 24 | May 28, 2026 | |
| ZTS Zoetis | Maintained: Buy | $145 → $112 | $75.35 | +48.64% | 2 | May 18, 2026 | |
| EVH Evolent Health | Maintained: Buy | $4 → $5.5 | $5.85 | -5.98% | 11 | May 15, 2026 | |
| AGL agilon health | Maintained: Hold | $19 → $80 | $125.78 | -36.40% | 9 | May 15, 2026 | |
| MCK McKesson | Rated: Buy | $860 → $945 | $828.84 | +14.01% | 15 | May 14, 2026 | |
| PAHC Phibro Animal Health | Rated: Hold | $62 → $44 | $33.86 | +29.95% | 2 | May 14, 2026 | |
| CTEV Claritev | Rated: Buy | $21 → $40 | $28.69 | +39.42% | 22 | May 14, 2026 | |
| GDRX GoodRx Holdings | Maintained: Buy | $3.5 → $4 | $3.02 | +32.45% | 28 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $26.31 | +21.63% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3.25 → $5 | $3.42 | +46.20% | 24 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $28 | $32.73 | -14.45% | 48 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $355 | $303.07 | +17.13% | 14 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $31 | $25.48 | +21.66% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $11 | $13.65 | -23.08% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $7 | $9.71 | -27.91% | 38 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 → $30 | $21.51 | +39.47% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $244 → $245 | $227.09 | +7.89% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $100 | $85.86 | +16.47% | 1 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $650 | $552.46 | +17.66% | 1 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $29 | $26.93 | +7.69% | 1 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.25 → $2.75 | $2.10 | +30.95% | 18 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.80 | n/a | 1 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.25 → $1.75 | $0.744 | n/a | 10 | Sep 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $19 → $8 | $14.19 | n/a | 9 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $9 | $1.45 | n/a | 14 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $11 | $0.0001 | n/a | 6 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $5.22 | n/a | 8 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.15 → $0.45 | $0.000001 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $11.21 | n/a | 1 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $32.24 | n/a | 1 | Nov 19, 2019 |
GMR Solutions
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $12.99
Upside: +30.87%
Align Technology
May 28, 2026
Maintained: Buy
Price Target: $240
Current: $177.50
Upside: +35.21%
Phreesia
May 28, 2026
Reiterated: Hold
Price Target: $10 → $12
Current: $10.60
Upside: +13.21%
Zoetis
May 18, 2026
Maintained: Buy
Price Target: $145 → $112
Current: $75.35
Upside: +48.64%
Evolent Health
May 15, 2026
Maintained: Buy
Price Target: $4 → $5.5
Current: $5.85
Upside: -5.98%
agilon health
May 15, 2026
Maintained: Hold
Price Target: $19 → $80
Current: $125.78
Upside: -36.40%
McKesson
May 14, 2026
Rated: Buy
Price Target: $860 → $945
Current: $828.84
Upside: +14.01%
Phibro Animal Health
May 14, 2026
Rated: Hold
Price Target: $62 → $44
Current: $33.86
Upside: +29.95%
Claritev
May 14, 2026
Rated: Buy
Price Target: $21 → $40
Current: $28.69
Upside: +39.42%
GoodRx Holdings
May 14, 2026
Maintained: Buy
Price Target: $3.5 → $4
Current: $3.02
Upside: +32.45%
May 13, 2026
Maintained: Buy
Price Target: $32
Current: $26.31
Upside: +21.63%
May 12, 2026
Rated: Buy
Price Target: $3.25 → $5
Current: $3.42
Upside: +46.20%
May 12, 2026
Rated: Hold
Price Target: $24 → $28
Current: $32.73
Upside: -14.45%
May 7, 2026
Maintained: Buy
Price Target: $355
Current: $303.07
Upside: +17.13%
May 7, 2026
Maintained: Buy
Price Target: $30 → $31
Current: $25.48
Upside: +21.66%
May 6, 2026
Maintained: Sell
Price Target: $10 → $11
Current: $13.65
Upside: -23.08%
May 5, 2026
Rated: Hold
Price Target: $6 → $7
Current: $9.71
Upside: -27.91%
May 5, 2026
Rated: Buy
Price Target: $35 → $30
Current: $21.51
Upside: +39.47%
May 1, 2026
Rated: Buy
Price Target: $244 → $245
Current: $227.09
Upside: +7.89%
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $100
Current: $85.86
Upside: +16.47%
Apr 16, 2026
Initiated Coverage: Hold
Price Target: $650
Current: $552.46
Upside: +17.66%
Apr 16, 2026
Initiated Coverage: Hold
Price Target: $29
Current: $26.93
Upside: +7.69%
Jan 9, 2026
Maintained: Hold
Price Target: $3.25 → $2.75
Current: $2.10
Upside: +30.95%
May 29, 2024
Maintained: Buy
Price Target: n/a
Current: $23.80
Upside: n/a
Sep 14, 2023
Maintained: Hold
Price Target: $1.25 → $1.75
Current: $0.744
Upside: n/a
Aug 4, 2023
Downgraded: Sell
Price Target: $19 → $8
Current: $14.19
Upside: n/a
May 18, 2023
Maintained: Hold
Price Target: $7 → $9
Current: $1.45
Upside: n/a
Mar 9, 2023
Maintained: Hold
Price Target: $15 → $11
Current: $0.0001
Upside: n/a
Mar 1, 2023
Maintained: Hold
Price Target: $1
Current: $5.22
Upside: n/a
Nov 15, 2022
Maintained: Hold
Price Target: $1.15 → $0.45
Current: $0.000001
Upside: n/a
Dec 11, 2019
Initiated Coverage: Buy
Price Target: $13
Current: $11.21
Upside: n/a
Nov 19, 2019
Initiated Coverage: Buy
Price Target: $28
Current: $32.24
Upside: n/a